1,038 results found

The Indian Patent Office has passed an order on 3 September 2015 rejecting patent application no. 991/MUMNP/2003 to Pfizer Products, Inc. for rheumatoid arthritis drug ‘Tofacitinib'.

The GSTAT Bench at Thane has dismissed Revenue department’s appeal filed against the appellate authority’s decision allowing exemption under Sl. No. 9 of Notification No. 02/2017-CT(R) to the assessee who was using manufacturer’s name...

On 16 December 2024 the Ministry of Information and Broadcasting (MIB) published an advisory for OTT platforms on streaming content related to narcotic drugs and psychotropic substances (Advisory).

This edition of Flash apprises you with the major developments in the food and pharmaceutical sector this month.

Increasing awareness about the benefits of healthier lifestyle has led to the deviation towards proper eating.

In a recent judgment, the Hon'ble Delhi High Court's decision on April 04, 2024, in the case of Kaira District Cooperative Milk Producers Union India Ltd.

Everyone around the globe is suffering from the Covid-19 pandemic and several industries are trying to overcome the economic turmoil.

United Nation Ad hoc Interagency Coordinating Group has recently published a report "Antimicrobial Resistance drug-resistant diseases" that warns that an urgent action needs to be taken at ground level ...

The Food Safety and Standards Authority of India (FSSAI) has issued an advisory dated 28th May 2025, addressing a growing concern in the food industry.

If the financial year 2023-24 (FY24) was defined by optimism, recovery, and growth narratives, FY25 brought a necessary pause. Consumption slowed across several categories, especially discretionary ones.

The Delhi High Court, on January 01, 2019, set aside the Central Government's ban on Wockhardt's anti-inflammatory medicine ‘Ace Proxyvon', a Fixed Dose combination of Aceclofenac 100 mg, Paracetamol 325 mg ...

The Hon'ble Finance Minister presented the Union Budget 2025 on 01 February 2025 in the Lok Sabha.

The NPPA has recently issued an office memorandum to clarify the doubts raised by manufacturers and retailers regarding implementation of prices of drugs revised in accordance with the DPCO from time to time.

The Supreme Court has asked the government to discuss with states all facets of a legal framework to regulate and monitor clinical trials of new drugs by foreign firms across India.

The FSSAI has launched a new mobile application ("App") which allows food business operators to check their compliance and allows customers to raise complaints regarding food safety.

The Union Health Ministry has amended the responsibilities of sponsors, investigators and the ethics committees in clinical trials.

On 28 November 2025 the Food Safety and Standards Authority of India invoked its emergency steering power under Section 16(5) of the Food Safety and Standards Act, 2006 to issue Order RCD-15001/16/2025-Regulatory.

The Food Safety and Standards Authority of India (FSSAI) has issued a press release on April 20, 2021, wherein they have issued directions for facilitating food businesses during the prevailing...